Sponsored by the National Institutes of Health (NIH), a Chinese vaccine against the Hepatitis E virus (HEV) has been approved by the U.S. Food and Drug Administration (FDA). Clinical trials will commence in April of 2019. Sold under the trade name Hecolin, it was...